PAM
VTVT icon

Panagora Asset Management’s vTv Therapeutics VTVT Stock Holding History

Panagora Asset Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13
Closed -$1K – 2933
2020
Q4 		$1K Hold
13
– – ﹤0.01% 2753
2020
Q3 		$1K Buy
+13
New +$1.14K ﹤0.01% 2667
2019
Q1 		– Sell
-748
Closed -$79K – 2579
2018
Q4 		$79K Sell
748
-401
-35% -$37.1K ﹤0.01% 1867
2018
Q3 		$35K Buy
+1,149
New +$53.9K ﹤0.01% 2108
2018
Q2 		– Sell
-122
Closed -$20K – 2426
2018
Q1 		$20K Sell
122
-6
-5% -$1.47K ﹤0.01% 2207
2017
Q4 		$31K Buy
+128
New +$28.7K ﹤0.01% 2123

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Panagora Asset Management's VTVT Position: Q1 2021 in Review

Panagora Asset Management sold out of vTv Therapeutics (VTVT) in Q1 2021, closing a stake of 13 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in VTVT in Q4 2017 and held it in 6 quarters. The position peaked at $79K in Q4 2018. 48 funds tracked by Wall St. Rank hold VTVT as of Q1 2021.

  • Panagora Asset Management reported no remaining vTv Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 13 vTv Therapeutics shares in Q1 2021, an estimated $1K.
  • Panagora Asset Management first reported a position in vTv Therapeutics in Q4 2017 and held it in 6 quarters.
  • Panagora Asset Management's vTv Therapeutics position peaked at $79K in Q4 2018.
  • 48 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.